trending Market Intelligence /marketintelligence/en/news-insights/trending/wzDNaRbHle3P-at5vrP_KA2 content esgSubNav
In This List

Bellicum appoints president, CEO

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


Bellicum appoints president, CEO

Rick Fair was appointed Bellicum Pharmaceuticals Inc.'s president, CEO and member of the company's board.

Fair succeeds Tom Farrell who would serve as an adviser to the company during the transition. Fair was senior vice president and head of oncology global product strategy at Genentech, a Roche Holding Ltd. subsidiary.